Clinical Trial

A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants

Name: A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants — clinical trial record (NCT07606976)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-controlled, single ascending dose phase I clinical study to evaluate the safety, tolerability, PK, PD and immunogenicity of SSS68 in healthy adult participants following a single subcutaneous administration.

Trial Details

NCT Number	NCT07606976
Lead Sponsor	Shenyang Sunshine Pharmaceutical Co., LTD.
Conditions	Healthy
Enrollment	50 participants
Start Date	2026-06
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-26